Related Experiment Video
Updated: Dec 30, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
AIFM2 blocks ferroptosis independent of ubiquinol metabolism
Enyong Dai1, Wenlong Zhang1, Dan Cong1
1Department of Oncology and Hematology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, 130031, China.
Abstract:
Ferroptosis is a multi-step regulated cell death that is characterized by excessive iron accumulation and lipid peroxidation. Cancer cells can acquire resistance to ferroptosis by the upregulation of anti-ferroptotic proteins or by the downregulation of pro-ferroptotic proteins. Apoptosis-inducing factor mitochondria-associated 2 (AIFM2, also known as FSP1 or PRG3) has been recently demonstrated as an endogenous ferroptosis suppressor, but its mechanism remains obscure. Here, we show that AIFM2 blocks erastin-, sorafenib-, and RSL3-induced ferroptotic cancer cell death through a mechanism independent of ubiquinol, the reduced and active antioxidant form of coenzyme Q10. In contrast, AIFM2-dependent endosomal sorting complexes required for transport (ESCRT)-III recruitment in the plasma membrane is responsible for ferroptosis resistance through the activation of a membrane repair mechanism that regulates membrane budding and fission. Importantly, the genetic inhibition of the AIFM2-dependent ESCRT-III pathway increases the anticancer activity of sorafenib in a xenograft tumor mouse model. These findings shed new light on the mechanism involved in ferroptosis resistance during tumor therapy.
Insights
Apoptosis-inducing factor mitochondria-associated 2 (AIFM2) suppresses ferroptosis by recruiting ESCRT-III to repair cell membranes, independent of ubiquinol. Inhibiting this pathway enhances cancer therapy effectiveness.
Area of Science:
- Cell Biology
- Biochemistry
- Oncology
Background:
- Ferroptosis is a regulated cell death pathway implicated in cancer.
- Cancer cells develop ferroptosis resistance via protein expression changes.
- The mechanism of ferroptosis suppressor AIFM2 (Apoptosis-inducing factor mitochondria-associated 2) was unclear.
Purpose of the Study:
- To elucidate the mechanism by which AIFM2 suppresses ferroptosis.
- To investigate the role of AIFM2 in ferroptosis resistance.
- To assess the therapeutic potential of targeting the AIFM2 pathway in cancer.
Main Methods:
- Investigated AIFM2's role in ferroptosis using cell culture models.
- Analyzed AIFM2's interaction with ubiquinol and ESCRT-III.
- Utilized a xenograft tumor mouse model to evaluate therapeutic inhibition.
Main Results:
- AIFM2 inhibits ferroptosis independently of ubiquinol.
- AIFM2-dependent ESCRT-III recruitment to the plasma membrane mediates ferroptosis resistance via membrane repair.
- Genetic inhibition of the AIFM2-ESCRT-III pathway potentiated sorafenib's anticancer activity in vivo.
Conclusions:
- AIFM2 confers ferroptosis resistance through an ESCRT-III-mediated membrane repair pathway.
- Targeting the AIFM2-ESCRT-III axis represents a potential strategy to overcome ferroptosis resistance in cancer therapy.
Related Concept Videos
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Electron Transport Chain: Complex III and IV
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
ATP Synthase: Mechanism

